A Comparison of Three Thromboprophylaxis Regimens in Critically Ill COVID-19 Patients: an Analysis of Real-World Data.
Ahmed Alrashed,Peter Cahusac,Yahya A. A. Mohzari,Reem F. F. Bamogaddam,Mashael Alfaifi,Maya Mathew,Bashayer F. F. Alrumayyan,Basmah F. F. Alqahtani,Amjad Alshammari, Kholud AlNekhilan,Aljawharah Binrokan, Khalil Alamri,Abdullah Alshahrani, Safar Alshahrani, Ahmad S. S. Alanazi,Batool M. M. Alhassan,Ali Alsaeed,Wedad Almutairi,Asma Albujaidy, Lama AlJuaid,Ziyad S. S. Almalki,Nehad Ahmed,Hamdan N. N. Alajami,Hala M. M. Aljishi,Mohammed Alsheef,Saleh A. A. Alajlan,Faisal Almutairi, Atheer Alsirhani, Manayer Alotaibi, Melaf A. A. Aljaber,Hammam A. A. Bahammam, Hussain Aldandan, Abdulaziz S. S. Almulhim,Ivo Abraham,Ahmad Alamer Frontiers in cardiovascular medicine（2022）
关键词
thromboprophylaxis doses,critically ill patients,COVID-19,mortality,thromboprophylaxis
AI 理解论文
溯源树
样例
